Evidence map›Paper›PMID 39466641›Full record

ArticleAllergy2025

STING-dependent induction of neutrophilic asthma exacerbation in response to house dust mite.

Yasmine Messaoud-Nacer, Elodie Culerier, Stéphanie Rose, Isabelle Maillet, Rania Boussad, Chloé Veront, Florence Savigny, Bernard Malissen, Urszula Radzikowska, Milena Sokolowska and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in Allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01159782 (Human Model of Rhinovirus Induced Acute Asthma Exacerbations), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01159782 nacompletednot on this map

Human Model of Rhinovirus Induced Acute Asthma Exacerbations

TypeinterventionalSponsorImperial College LondonRan2011 to 2014Enrolled46ConditionsRhinovirus Infection in AsthmaArmsRhinovirus infection
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Beyond Type 2 Inflammation: Why Neutrophils Deserve a Central Role in Refractory Airway Disease.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Article
  3. Review
  4. Review
  5. Asthma endotypes and theratypes.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS.Apoptosis : an international journal on programmed cell death · 2025
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yasmine Messaoud-NacerExperimental and Molecular Immunology and Neurogenetics, INEM UMR7355 University of Orleans and CNRS, Orleans, France.
Elodie CulerierExperimental and Molecular Immunology and Neurogenetics, INEM UMR7355 University of Orleans and CNRS, Orleans, France.
Stéphanie RoseExperimental and Molecular Immunology and Neurogenetics, INEM UMR7355 University of Orleans and CNRS, Orleans, France.
Isabelle MailletExperimental and Molecular Immunology and Neurogenetics, INEM UMR7355 University of Orleans and CNRS, Orleans, France.
Rania BoussadExperimental and Molecular Immunology and Neurogenetics, INEM UMR7355 University of Orleans and CNRS, Orleans, France.
Chloé VerontExperimental and Molecular Immunology and Neurogenetics, INEM UMR7355 University of Orleans and CNRS, Orleans, France.
Florence SavignyExperimental and Molecular Immunology and Neurogenetics, INEM UMR7355 University of Orleans and CNRS, Orleans, France.
Bernard MalissenCentre d'Immunophénomique (CIPHE), Aix Marseille Université, INSERM, CNRS, Marseille, France.ORCID https://orcid.org/0000-0003-1340-9342
Urszula RadzikowskaSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0002-7341-9764
Milena SokolowskaSwiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.ORCID https://orcid.org/0000-0001-9710-6685
Gabriel V L da SilvaRibeirão Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil.
Michael R EdwardsNational Heart and Lung Institute, Imperial College Londont, London, UK.
David J JacksonGuy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust, London, UK.ORCID https://orcid.org/0000-0002-2299-868X
Sebastian L JohnstonNational Heart and Lung Institute, Imperial College Londont, London, UK.ORCID https://orcid.org/0000-0003-3009-9200
Bernhard RyffelExperimental and Molecular Immunology and Neurogenetics, INEM UMR7355 University of Orleans and CNRS, Orleans, France.ORCID https://orcid.org/0000-0003-2897-8230
Valerie F QuesniauxExperimental and Molecular Immunology and Neurogenetics, INEM UMR7355 University of Orleans and CNRS, Orleans, France.ORCID https://orcid.org/0000-0003-2907-7995
Dieudonnée TogbeExperimental and Molecular Immunology and Neurogenetics, INEM UMR7355 University of Orleans and CNRS, Orleans, France.ORCID https://orcid.org/0000-0001-6658-414X

Funding

ANR-10-INSB-07 and CIPHEChair from Asthma UKConseil Régional du Centre-Val de LoireEuropean Regional Development Fund in Region Centre Val de Loire N°2024-00012066Exposome&InflammationEuropean Research CouncilFondation pour la Recherche Médicaleinvestissement d'avenir programme PHENOMINNational Institute for Health and Care ResearchNIHR Biomedical Research Centre at Imperial College LondonSNSF grant nr 310030_189334/1
6 · The paper itself

Abstract

backgroundSevere refractory, neutrophilic asthma remains an unsolved clinical problem. STING agonists induce a neutrophilic response in the airways, suggesting that STING activation may contribute to the triggering of neutrophilic exacerbations. We aim to determine whether STING-induced neutrophilic lung inflammation mimics severe asthma.

methodsWe developed new models of neutrophilic lung inflammation induced by house dust mite (HDM) plus STING agonists diamidobenzimidazole (diABZI) or cGAMP in wild-type, and conditional-STING-deficient mice. We measured DNA damage, cell death, NETs, cGAS/STING pathway activation by immunoblots, N1/N2 balance by flow cytometry, lung function by plethysmography, and Th1/Th2 cytokines by multiplex. We evaluated diABZI effects on human airway epithelial cells from healthy or patients with asthma, and validated the results by transcriptomic analyses of rhinovirus infected healthy controls vs patients with asthma.

resultsDiABZI administration during HDM challenge increased airway hyperresponsiveness, neutrophil recruitment with prominent NOS2

conclusionsOur study identifies that triggering STING in the context of asthma induces cell death by PANoptosis, fueling the flame of inflammation through a mixed Th1/Th2 immune response recapitulating the features of severe asthma with a prognostic signature of type 1 neutrophils.

Indexed as

AsthmaMembrane ProteinsNeutrophilsPyroglyphidaeAnimalsCytokinesDisease Models, AnimalDisease ProgressionFemaleHumansMiceSTING ProteinCytokinesMembrane ProteinsSTING1 protein, humanSting1 protein, mouseSTING Proteinasthma exacerbationcell deathcGAMPdiABZIDNA sensingwith inserts

Identifiers

PMID39466641
PMCPMC11891437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.